000			01593 a2200433 4500
005			20250514222435.0
264		0	_c20050819
008			200508s 0 0 eng d
022			_a0268-3369
024	7		_a10.1038/sj.bmt.1704863 _2doi
040			_aNLM _beng _cNLM
100	1		_aBlijlevens, N M A
245	0	0	_aProspective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. _h[electronic resource]
260			_bBone marrow transplantation _cApr 2005
300			_a707-11 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAnthracyclines _xadverse effects
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aFemale
650	0	4	_aHematologic Neoplasms _xcomplications
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aIdarubicin _xadverse effects
650	0	4	_aIntestinal Mucosa _xdrug effects
650	0	4	_aLactulose _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyeloablative Agonists _xadverse effects
650	0	4	_aPermeability _xdrug effects
650	0	4	_aProspective Studies
650	0	4	_aRhamnose _xmetabolism
650	0	4	_aStomatitis _xchemically induced
650	0	4	_aTransplantation Conditioning _xadverse effects
700	1		_aDonnelly, J P
700	1		_ade Pauw, B E
773	0		_tBone marrow transplantation _gvol. 35 _gno. 7 _gp. 707-11
856	4	0	_uhttps://doi.org/10.1038/sj.bmt.1704863 _zAvailable from publisher's website
999			_c15457241 _d15457241